Linezolid, vancomycin and daptomycin modulate cytokine production, Toll-like receptors and phagocytosis in a human in vitro model of sepsis

The Journal of Antibiotics
Christian BodeGeorg Baumgarten

Abstract

Conventional antibiotics exhibit immunomodulatory properties beneficial in the treatment of sepsis. Antibiotic-resistant Gram-positive bacteria have become a problem in sepsis therapy, giving rise to increased use of last-resort antibiotics; for example, linezolid (LIN), vancomycin (VAN) and daptomycin (DAP). As the immunomodulatory properties of these antibiotics in treating sepsis are unknown, this study examined the effect of VAN, LIN and DAP on the immune response under sepsis-like conditions in vitro. Lipopolysaccharide (LPS)-activated THP-1 monocytes were incubated with LIN, VAN or DAP. Gene expression of cytokines (TNFα, IL-1β, IL-6, IL-10) and Toll-like receptors (TLR1, 2, 4, 6, 7 and 9) was monitored and phagocytosis was determined following coincubation with E. coli. The antibiotics differentially modulated the gene expression of the investigated cytokines. While LIN and VAN upregulated the expression of all TLRs, DAP downregulated mRNA levels of TLR1, TLR2 and TLR6, which recognize pathogen-associated molecular patterns from Gram-positive bacteria. In addition, LIN inhibited, whereas VAN promoted the phagocytic activity of monocytes. Our results suggest that LIN and VAN possess pro-inflammatory properties, whereas DA...Continue Reading

References

Dec 25, 2003·Antimicrobial Agents and Chemotherapy·Evangelos J Giamarellos-BourboulisHelen Giamarellou
May 15, 2004·Science·J Magarian Blander, Ruslan Medzhitov
Dec 23, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy R Pasquale, James S Tan
Nov 30, 2005·Archives of Medical Research·Pilar Garcia-RocaErnesto Calderon-Jaimes
May 16, 2006·European Journal of Pharmacology·Vanesa Ivetić TkalcevićVesna Eraković
Aug 31, 2006·Acta Anaesthesiologica Scandinavica·S ZiegelerH Rensing
Sep 20, 2006·Antimicrobial Agents and Chemotherapy·Pavlos MyrianthefsGeorgios Baltopoulos
Oct 17, 2007·Antimicrobial Agents and Chemotherapy·Mitsuhiro IyoriKen-ichiro Shibata
Dec 8, 2007·The Lancet Infectious Diseases·Tom van der Poll, Steven M Opal
May 1, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Evangelos J Giamarellos-BourboulisHelen Giamarellou
Sep 20, 2008·Nature Reviews. Immunology·Daniel RittirschPeter A Ward
Dec 17, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mark H WilcoxCharles Knirsch
Feb 3, 2009·Proceedings of the National Academy of Sciences of the United States of America·Thierry RogerThierry Calandra
Jan 18, 2011·International Reviews of Immunology·Himanshu KumarShizuo Akira
Jul 5, 2012·Chemotherapy·Thomas GrügerJosef Zündorf
Nov 9, 2012·Journal of Leukocyte Biology·Monowar AzizPing Wang
Aug 21, 2013·Immunity·Shankar S IyerFayyaz S Sutterwala
Dec 18, 2013·Virulence·Florian B MayrDerek C Angus

❮ Previous
Next ❯

Citations

May 14, 2016·Environmental Science and Pollution Research International·Panzi QiuNa Wang
Apr 9, 2017·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Jonathan G SeaveyThomas A Davis
Jul 17, 2016·Applied and Environmental Microbiology·Suzanne YoungValerie J Harwood
Oct 24, 2017·The Journal of Antimicrobial Chemotherapy·Mohsen HeidaryMehdi Goudarzi
Jul 3, 2019·BioMed Research International·Yang YeShufang Liang
Sep 10, 2020·Antibiotics·Marquerita Algorri, Annie Wong-Beringer
Dec 19, 2019·Frontiers in Pharmacology·Jin WangYun Cai
Oct 13, 2020·Frontiers in Cellular and Infection Microbiology·Christina CahillJoseph Keane
Jan 7, 2021·The American Journal of Sports Medicine·Caroline M AthertonMoeed Akbar
Jun 9, 2020·Medical Hypotheses·Muhammad AsaduzzamanEmily Rousham
Nov 5, 2020·Annals of Clinical Microbiology and Antimicrobials·Marquerita Algorri, Annie Wong-Beringer
May 6, 2021·Macromolecular Bioscience·Matin RostamitabarSamaneh Ghazanfari
Jul 24, 2021·International Journal of Immunopathology and Pharmacology·Stefan MuensterChristina Katharina Weisheit
Oct 8, 2021·European Respiratory Review : an Official Journal of the European Respiratory Society·Andrea SauerChristian Bode

❮ Previous
Next ❯

Methods Mentioned

BETA
FCS
PCR

Software Mentioned

SDS
FlowJo Analysis
GraphPad Prism

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.